Zhang, E., Gu, J., & Xu, H. (2018). Prospects for chimeric antigen receptor-modified T cell therapy for solid tumors. Mol Cancer.
Chicago Style CitationZhang, Erhao, Jieyi Gu, i Hanmei Xu. "Prospects for Chimeric Antigen Receptor-modified T Cell Therapy for Solid Tumors." Mol Cancer 2018.
Cita MLAZhang, Erhao, Jieyi Gu, i Hanmei Xu. "Prospects for Chimeric Antigen Receptor-modified T Cell Therapy for Solid Tumors." Mol Cancer 2018.
Atenció: Aquestes cites poden no estar 100% correctes.